Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells

References

• HiipakkaRALiaoSMolecular mechanism of androgen actionTrends Endocrinol Metab19989831732418406296
   PubMed Web of Science ®Google Scholar
• BalaschJFábreguesFCasamitjanaRPeñarrubiaJVanrellJAA pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndromeReprod Biomed Online20036329630112735863
   PubMedGoogle Scholar
• JemalASiegelRWardECancer statisticsCA Cancer J Clin2007571436617237035
   PubMed Web of Science ®Google Scholar
• MiyataYNomataKOhbaKUse of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysisCancer Chemother Pharmacol201270345145922864875
   PubMed Web of Science ®Google Scholar
• LiQQWangGReedEHuangLCuffCFEvaluation of cisplatin in combination with b-elemene as a regimen for prostate cancer chemotherapyBasic Clin Pharmacol Toxicol2010107586887622545969
   PubMed Web of Science ®Google Scholar
• YeruvaLHallCElegbedeJACarperSWPerillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatinAnti-Cancer Drugs20102111919820395
   PubMed Web of Science ®Google Scholar
• KimYHShinSWKimBSPaclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinomaCancer199985229530110023695
   PubMed Web of Science ®Google Scholar
• CunninghamKGHutchinsonSAMansonWHutchinsonSACordycepin, a metabolic product isolated from cultures of Cordyceps militarisNature1950166423194914796634
   PubMed Web of Science ®Google Scholar
• JenCYLinCYHuangBMLeuSFCordycepin induced MA-10 mouse Leydig tumor cell apoptosis through caspase-9 pathwayEvid Based Complement Alternat Med2011201198453719131393
   PubMed Web of Science ®Google Scholar
• PanBSLinCYHuangBMThe effect of cordycepin on steroidogenesis and apoptosis in MA-10 mouse Leydig tumor cellsEvid Based Complement Alternat Med2011201175046821716681
   PubMed Web of Science ®Google Scholar
• WuWCHsiaoJRLianYYLinCYHuangBMThe apoptotic effect of cordycepin on human OEC-M1 oral cancer cell lineCancer Chemother Pharmacol200760110311117031645
   PubMed Web of Science ®Google Scholar
• NakamuraKYoshikawaNYamaguchiYKagotaSShinozukaKKunitomoMAntitumor effect of cordycepin (3-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulationAnticancer Res2006261A434716475677
   PubMed Web of Science ®Google Scholar
• ThomadakiHTsiapalisCMScorilasAPolyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis inductionBiol Chem2005386547148015927891
   PubMed Web of Science ®Google Scholar
• AhnHJKimYSKimJUHanSMShinJWYangHOMechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cellsJ Biol Chem200491510431052
   Google Scholar
• RowinskyEKDonehowerRCPaclitaxel (Taxol)N Engl J Med199533215100410147885406
   PubMed Web of Science ®Google Scholar
• RosenbergBPlatinum complexes for the treatment of cancer: why the search goes onLippertBCisplatin: Chemistry and Biochemistry of a Leading Anticancer DrugZürich, SwitzerlandVerlag Helvetica Chimica Acta2006
   Google Scholar
• JohnstoneTCParkGYLippardSJUnderstanding and improving platinum anticancer drugs – phenanthriplatinAnticancer Res201434147147624403503
   PubMed Web of Science ®Google Scholar
• FuertesMACastillaJAlonsoCPérezJMCisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathwaysCurr Med Chem200310325726612570712
   PubMed Web of Science ®Google Scholar
• AshkenaziADixitVMDeath receptors: signaling and modulationScience19982815381130513089721089
   PubMed Web of Science ®Google Scholar
• GuptaSMolecular steps of cell suicide: an insight into immune senescenceJ Clin Immunol200020422924010939710
   PubMed Web of Science ®Google Scholar
• ThornberryNALazebnikYCaspases: enemies withinScience19982815381131213169721091
   PubMed Web of Science ®Google Scholar
• BoularesAHYakovlevAGIvanovaVRole of poly (ADP-ribose) polymerase (PARP) cleavage in apoptosis-caspase 3 resistant PARP mutant increases rates of apoptosis in transfected cellsJ Biol Chem199927433229322294010438458
   PubMed Web of Science ®Google Scholar
• WadaTPenningerJMMitogen-activated protein kinases in apoptosis regulationOncogene200423162838234915077147
   PubMed Web of Science ®Google Scholar
• ReinhardtHCSchumacherBThe p53 network: cellular and systemic DNA damage responses in aging and cancerTrends Genet201228312813622265392
   PubMed Web of Science ®Google Scholar
• ChenYHWangJYPanBSCordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cellsOnco Targets Ther2013698399823926438
   PubMed Web of Science ®Google Scholar
• ChenYHHaoLJHungCPChenJWLeuSFHuangBMApoptotic effect of cisplatin and cordycepin on OC3 human oral cancer cellsChin J Integr Med201420862463223543357
   PubMed Web of Science ®Google Scholar
• GuptaSMolecular steps of death receptor and mitochondrial pathways of apoptosisLife Sci200169232957296411758823
   PubMed Web of Science ®Google Scholar
• LowryOHRosebroughNJFarrALRandallRJProtein measurement with the Folin phenol reagentJ Biol Chem1951193126527514907713
   PubMed Web of Science ®Google Scholar
• ChenYHLeuSFJenCYHuangBMEffects of sesamol on apoptosis and steroidogenesis in MA-10 mouse Leydig tumor cellsJ Agric Food Chem201159189885989121863802
   PubMed Web of Science ®Google Scholar
• LeeSJKimSKChoiWSKimWJMoonSKCordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cellsArch Biochem Biophys2009490210310919733546
   PubMed Web of Science ®Google Scholar
• LiWMeltonDWCisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistanceOncogene201231192412242221996734
   PubMed Web of Science ®Google Scholar
• SeidmanRGitelmanISagiOHorwitzSBWolfsonMThe role of ERK 1/2 and p38 MAP-kinase pathways in Taxol-induced apoptosis in human ovarian carcinoma cellsExp Cell Res20012681849211461121
   PubMed Web of Science ®Google Scholar
• HeinrichsSDeppertWApoptosis or growth arrest: modulation of the cellular response to p53 by proliferative signalsOncogene200322455557112555069
   PubMed Web of Science ®Google Scholar
• WuGSThe functional interactions between the p53 and MAPK signaling pathwaysCancer Biol Ther200431215616114764989
   PubMed Web of Science ®Google Scholar
• DamiaGFilibertiLVikhanskayaFCisplatinum and taxol induce different patterns of p53 phosphorylationNeoplasia200131101611326311
   PubMed Web of Science ®Google Scholar
• MonsuezJJCharniotJCVignatNArtigouJYCardiac side-effects of cancer chemotherapyInt J Cardiol2010144131520399520
   PubMed Web of Science ®Google Scholar
• CavalettiGPeripheral neurotoxicity of platinum-based chemotherapyNat Rev Cancer2008811
   Web of Science ®Google Scholar
• TurnerNPearsonASharpeRFGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerCancer Res20107052085209420179196
   PubMed Web of Science ®Google Scholar
• SawadaSMeseHSasakiAYoshiokaNMatsumuraTCombination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell lineCancer Chemother Pharmacol200351650551112709826
   PubMed Web of Science ®Google Scholar
• DrewinkoBGreenCLooTLCombination chemotherapy in vitro with cis-dichlorodiammineplatinum(II)Cancer Treat Rep19766011161916251021234
   PubMedGoogle Scholar
• HigginbottomKJahnkeUNewlandACCotterFEAllenPDNew alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosisApoptosis200712101847185517636382
   PubMed Web of Science ®Google Scholar
• ShapiroGIHarperJWAnticancer drug targets: cell cycle and checkpoint controlJ Clin Invest1999104121645165310606615
   PubMed Web of Science ®Google Scholar
• LingXBernackiRJBrattainMGLiFInduction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrestJ Biol Chem200427915151961520314722122
   PubMed Web of Science ®Google Scholar
• BacusSSGudkovAVLoweMTaxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53Oncogene200120214715511313944
   PubMed Web of Science ®Google Scholar
• SorensonCMBarryMAEastmanAAnalysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatinJ Natl Cancer Inst19908297497551691303
   PubMed Web of Science ®Google Scholar
• WeirNMSelvendiranKKutalaVKCurcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPKCancer Biol Ther20076217818417218783
   PubMed Web of Science ®Google Scholar
• PalayoorSTMacklisRMBumpEAColemanCNModulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cellsRadiat Res199514132352437871150
   PubMed Web of Science ®Google Scholar
• BoulikasTVougioukaMRecent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review)Onco Rep2004113559595
   Google Scholar
• KaufmannSHCell death induced by topoisomerase-targeted drugs: more questions than answersBiochim Biophys Acta199814001–31951219748575
   PubMed Web of Science ®Google Scholar
• NagataSFas-mediated apoptosisAdv Exp Med Biol19964061191248910677
   PubMedGoogle Scholar
• SuzukiAShirakiKTumor cell “dead or alive”: caspase and survivin regulate cell death, cell cycle and cell survivalHistol Histopathol200116258359311332714
   PubMed Web of Science ®Google Scholar
• WesselborgSEngelsIHRossmannELosMSchulze-OsthoffKAnticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interactionBlood19999393053306310216102
   PubMed Web of Science ®Google Scholar
• KroemerGZamzamiNSusinSAMitochondrial control of apoptosisImmunol Today199718144519018974
   PubMedGoogle Scholar
• FerrariDStepczynskaALosMWesselborgSSchulze-OsthoffKDifferential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosisJ Exp Med199818859799849730899
   PubMed Web of Science ®Google Scholar
• FuldaSDebatinKMSensitization for anticancer drug-induced apoptosis by betulinic acidNeoplasia20057216217015802021
   PubMed Web of Science ®Google Scholar
• WangGQGastmanBRWieckowskiEA role for mitochondrial Bak in apoptotic response to anticancer drugsJ Biol Chem200127636343073431711447222
   PubMed Web of Science ®Google Scholar
• DanglePPZaharievaBJiaHPoharKSRas-MAPK pathway as a therapeutic target in cancer – emphasis on bladder cancerRecent Pat Anticancer Drug Discov20094212513619519535
   PubMed Web of Science ®Google Scholar
• TohWHSiddiqueMMBoominathanLLinKWSabapathyKC-Jun regulates the stability and activity of the p53 homologueJ Biol Chem200427943447134472215302867
   PubMed Web of Science ®Google Scholar
• HuRKimBRChenCHebbarVKongANThe roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cellsCarcinogenesis20032481361136712819185
   PubMed Web of Science ®Google Scholar
• EinhornLHDonohueJPImproved chemotherapy in disseminated testicular cancerJ Urol19771171656963574
   PubMed Web of Science ®Google Scholar
• HerrIDebatinKMCellular stress response and apoptosis in cancer therapyBlood20019892603261411675328
   PubMed Web of Science ®Google Scholar